Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020.

Catalonia HEV IgG IgM Spain acquisition route blood donors hepatitis E virus screening universal blood donor screening viral load virus RNA viruses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
01 2022
Historique:
entrez: 21 12 2021
pubmed: 22 12 2021
medline: 7 1 2022
Statut: ppublish

Résumé

Hepatitis E virus (HEV) is the major cause of acute viral hepatitis in several countries in Europe. HEV is acquired mainly by consumption of contaminated pork but can also be transmitted through blood transfusion. HEV infection is usually self-limited but can become persistent in immunocompromised persons. During the first 30 months of HEV RNA universal screening of blood donations in Catalonia, Spain, we identified 151 HEV RNA-positive donations (1/4,341 blood donations). Most infected donors reported consumption of pates and sausages, and 58% were negative for HEV IgM and IgG. All HEV isolates belonged to genotype 3. All infected donors spontaneously resolved the infection, and no neurologic symptoms and reinfections were observed after 1 year of follow-up. Since the implementation of HEV RNA universal screening, no new cases of transfusion-transmitted HEV infection were reported. Our data indicate HEV screening of blood donations provides safer blood for all recipients, especially for immunosuppressed persons.

Identifiants

pubmed: 34932460
doi: 10.3201/eid2801.211466
pmc: PMC8714212
doi:

Substances chimiques

Hepatitis Antibodies 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-165

Références

Ann Hepatol. 2013 Nov-Dec;12(6):861-70
pubmed: 24114815
Euro Surveill. 2013 Aug 01;18(31):
pubmed: 23929229
Transfusion. 2017 Jan;57(1):223-224
pubmed: 28097700
Front Med (Lausanne). 2018 Feb 01;5:5
pubmed: 29450199
J Viral Hepat. 2020 Jul;27(7):747-753
pubmed: 32106351
N Engl J Med. 2012 Sep 27;367(13):1237-44
pubmed: 23013075
Front Microbiol. 2020 Jan 28;10:2990
pubmed: 32047480
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
J Gen Virol. 2014 Oct;95(Pt 10):2223-2232
pubmed: 24989172
Front Microbiol. 2020 Jan 14;10:2937
pubmed: 31993027
Clin Infect Dis. 2020 Aug 22;71(5):1204-1211
pubmed: 31793638
Emerg Infect Dis. 2020 Dec;26(12):2881-2886
pubmed: 33219652
Clin Microbiol Infect. 2017 Sep;23(9):667-671
pubmed: 28285979
Transfusion. 2015 May;55(5):972-9
pubmed: 25403913
Transfus Med Hemother. 2019 Apr;46(2):95-103
pubmed: 31191195
Viruses. 2019 Jul 05;11(7):
pubmed: 31284466
J Gastroenterol Hepatol. 2009 Sep;24(9):1484-93
pubmed: 19686410
Transfus Med Rev. 2019 Jul;33(3):139-145
pubmed: 31324552
J Hepatol. 2018 Jun;68(6):1256-1271
pubmed: 29609832
J Viral Hepat. 2019 May;26(5):603-608
pubmed: 30661278
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862338
Transbound Emerg Dis. 2019 Mar;66(2):978-985
pubmed: 30597741
Lancet. 2014 Nov 15;384(9956):1766-73
pubmed: 25078306
J Gen Virol. 2015 Nov;96(11):3255-3264
pubmed: 26282123
J Hepatol. 2018 Jul;69(1):36-42
pubmed: 29551705
J Viral Hepat. 2019 Oct;26(10):1218-1223
pubmed: 31194897
Zoonoses Public Health. 2018 Feb;65(1):11-29
pubmed: 28944602
Environ Sci Technol. 2006 Dec 1;40(23):7416-22
pubmed: 17180997
Transfusion. 2018 Nov;58(11):2501-2505
pubmed: 30284732
Transfusion. 2017 Feb;57(2):244-247
pubmed: 27785789

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH